n-(3-(aminomethyl)benzyl)acetamidine has been researched along with 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, Y; Hao, L; Liu, Y; Lu, Q; Qin, W; Sheng, L; Wang, J; Wang, X; Wang, Y; Zhang, M; Zhao, T | 1 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone
Article | Year |
---|---|
Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
Topics: Amidines; Animals; Apoptosis; Benzylamines; Cardiotonic Agents; Caspase 3; Disease Models, Animal; Enzyme Inhibitors; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type II; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Ventricular Function | 2015 |